JEFFREY H JABLON

Allopathic & Osteopathic Physicians|Otolaryngology PURCHASE, NY NPI 1124068465

General Payments — all program years on this page

$6,178.47

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 284
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $907.16 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $907.1639

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $830.3247
2019 $534.0625
2020 $637.4832
2021 $450.9023
2022 $1,161.7549
2023 $1,656.8069
2024 $907.1639

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087106806 Novartis Pharmaceuticals Corporation $24.18 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087106808 Novartis Pharmaceuticals Corporation $23.68 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087106824 Novartis Pharmaceuticals Corporation $23.63 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087106826 Novartis Pharmaceuticals Corporation $24.37 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087106834 Novartis Pharmaceuticals Corporation $24.12 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087106838 Novartis Pharmaceuticals Corporation $24.83 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087106840 Novartis Pharmaceuticals Corporation $27.78 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087106854 Novartis Pharmaceuticals Corporation $28.94 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087106856 Novartis Pharmaceuticals Corporation $24.51 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087106868 Novartis Pharmaceuticals Corporation $25.65 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087106872 Novartis Pharmaceuticals Corporation $24.93 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087106874 Novartis Pharmaceuticals Corporation $20.00 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087106876 Novartis Pharmaceuticals Corporation $21.68 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105292621 AstraZeneca Pharmaceuticals LP $31.38 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105680351 AstraZeneca Pharmaceuticals LP $17.02 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105716434 AstraZeneca Pharmaceuticals LP $23.46 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116225033 GlaxoSmithKline, LLC. $14.15 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116352958 GlaxoSmithKline, LLC. $25.95 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116596577 GlaxoSmithKline, LLC. $29.71 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119864637 Stryker Corporation $15.33 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126625581 kaleo, Inc. $22.70 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126625583 kaleo, Inc. $21.25 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126625585 kaleo, Inc. $20.11 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126625587 kaleo, Inc. $21.85 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127507787 Hikma Pharmaceuticals USA $18.59 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127507849 Hikma Pharmaceuticals USA $50.50 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139603356 GENZYME CORPORATION $23.36 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139603376 GENZYME CORPORATION $21.11 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139603504 GENZYME CORPORATION $9.49 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139603508 GENZYME CORPORATION $35.29 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139603514 GENZYME CORPORATION $30.00 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139603562 GENZYME CORPORATION $22.12 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139603570 GENZYME CORPORATION $14.24 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139603596 GENZYME CORPORATION $28.61 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139603624 GENZYME CORPORATION $19.38 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142176122 Optinose US, Inc. $27.56 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142176138 Optinose US, Inc. $18.56 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148062021 Inspire Medical Systems, Inc. $13.28 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148062023 Inspire Medical Systems, Inc. $13.86 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.